about
Hepatitis B virus and hepatitis C virus infection in healthcare workersHepatitis B virus infection in immigrant populationsClinical significance of hepatitis B surface antigen mutantsLiver fibrosis in human immunodeficiency virus/hepatitis C virus coinfection: Diagnostic methods and clinical impact.Hepatitis C virus markers in infection by hepatitis C virus: In the era of directly acting antiviralsHepatitis C virus infection and prisoners: Epidemiology, outcome and treatmentCannabinoid receptor 2-63 QQ variant is associated with persistently normal aminotransferase serum levels in chronic hepatitis CEpidemiological and clinical scenario of chronic liver diseases in Italy: Data from a multicenter nationwide survey.Hepatic flares in chronic hepatitis C: spontaneous exacerbation vs hepatotropic viruses superinfection.Epidemiology of acute and chronic hepatitis B and delta over the last 5 decades in ItalyEfficacy of Pegylated interferon α-2a and α-2b in patients with genotype 1 chronic hepatitis C: a meta-analysis.Boceprevir is highly effective in treatment-experienced hepatitis C virus-positive genotype-1 menopausal women.Access to treatment for HBV infection and its consistency with 2008 European guidelines in a multicentre cross-sectional study of HIV/HBV co-infected patients in Italy.Liver microRNA hsa-miR-125a-5p in HBV chronic infection: correlation with HBV replication and disease progressionPeg-interferon plus ribavirin with or without boceprevir or telaprevir for HCV genotype 1: a meta-analysis on the role of response predictorsRole of genetic polymorphisms in hepatitis C virus chronic infection.Impact of comorbidities on the severity of chronic hepatitis B at presentationRituximab-based treatment, HCV replication, and hepatic flares.Hepatitis B virus burden in developing countries.Naturally occurring mutations associated with resistance to HCV NS5B polymerase and NS3 protease inhibitors in treatment-naïve patients with chronic hepatitis C.Hepatitis B virus infection in undocumented immigrants and refugees in Southern Italy: demographic, virological, and clinical features.Clinical applications of antibody avidity and immunoglobulin M testing in acute HCV infection.Acute hepatitis C: clinical and laboratory diagnosis, course of the disease, treatment.Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection.Treatment of chronic hepatitis C in patients with HIV/HCV coinfectionEtiological factors of chronic hepatitis in Italy: a 2014 national survey.Clinical impact of the hepatitis C virus mutations in the era of directly acting antivirals.Occult HBV infection in the oncohematological setting.Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection in undocumented migrants and refugees in southern Italy, January 2012 to June 2013.Lipodystrophy and serum lipid abnormalities in HIV-positive sub-Saharan population on ART.Fibrosis progression in paired liver biopsies from HIV/HCV co-infected patients.Molecular diversity in irregular or refugee immigrant patients with HBV-genotype-E infection living in the metropolitan area of Naples.Influence of universal HBV vaccination on chronic HBV infection in Italy: Results of a cross-sectional multicenter study.Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology.Hepatitis delta infection in Italian patients: towards the end of the story?Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patients.PrEP in Italy: The time may be ripe but who's paying the bill? A nationwide survey on physicians' attitudes towards using antiretrovirals to prevent HIV infection.The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9,997 cases.TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotype.Association between anti-HBc positivity and hepatocellular carcinoma in HBsAg-negative subjects with chronic liver disease: A meta-analysis.
P50
Q26765801-A1DBDAB6-5AE4-4552-B347-98527FD704B9Q26771150-E9280A93-7EC6-41D6-A521-097EE8D57C48Q26773676-09087C28-3C2F-4044-A884-3DEBDF7F06A1Q26777511-05A4D164-3A7A-49B4-8662-179AB6097994Q26782033-314C0CAB-6B4D-44F1-94E4-054A06BBBFF1Q26785981-BF382724-3D6E-440E-BF0F-D93BD4280500Q28539814-B21CA0D3-B8F5-49AD-B0E1-B940AE12E826Q31107505-AB1F12A3-18B7-4BB8-B262-150BA0A6CB1CQ33735206-0CC3F458-42BF-4F5B-86C2-FAD6623DBD42Q33801300-AA25F0B6-1DF0-41E6-8A0A-AAE15B5E0D83Q34514292-BA73C3B8-92D8-44F6-A508-18C9E98D8217Q34589830-A12ABE0E-A101-4B74-A2DC-A8B97795741CQ34675557-95F7BC10-A90F-4F82-96F9-88701FB25AECQ34811974-37B6AC22-4AAD-4AF7-AAC2-B22EEB3CD6F4Q35146790-70B10BFD-1C37-4C41-9F14-0C4196BCA590Q35779058-49F8365E-9E81-4021-ADBA-54FBC5452F91Q35886670-17976ED8-631F-4227-BA28-9559824E079DQ36167378-B297C435-2B19-44AA-A52E-510CE964A381Q36269649-0C9C7964-514F-4C16-8D23-1FB3D26ADE2BQ36292486-0367FAA8-08F4-417C-B689-FC8274AD405DQ37633770-6A3B802D-1BC5-4B7D-BC5D-370E1F32C286Q38074390-3EE3D301-CA45-42EE-BE7A-EB47237B512DQ38195262-11DB983A-79A5-44FF-A9F2-A16D34D14641Q38207725-EC199587-E15B-4CF0-8657-CBEAFE694410Q38352572-1B7E7376-3883-4541-8931-4BFDB3D6927AQ38679799-42D5390F-A06C-412E-B0DF-0B9E94DA3DB9Q38779980-C5BB365B-402B-4EAA-B800-71A8687EC5AFQ38807875-E9259F4A-39B6-4C43-A9C6-E064473B4887Q38952987-96AF2148-ED28-431C-B3F4-6D74137AA077Q39004446-2D73A937-BD7C-40D3-B52C-C866A4E836E7Q39018310-17269DEA-AF4B-404B-B324-D6E159871F9DQ39224652-0DEE85FC-1BDE-4774-9034-78AB6F4374DAQ39419887-18275481-23DA-4ABD-B55E-5865FE954156Q39494125-4E248182-62C7-42D2-AD4A-6C2ADAD71168Q39494133-8DE14DCE-772F-4034-98C0-910A1EA742F0Q40113130-C5197359-FD38-470A-ACB8-026923ACBD8DQ40126361-30AB10A3-CA26-4E98-8A74-ECCC3C3F9166Q40445497-B3A5EBB8-CE1C-432A-82F6-A29A84F42A6DQ40482870-77181D3E-BD0E-4BB8-986D-FB9C0F5D2FB3Q40595308-C3784656-7449-41B4-A041-AD8614D564E1
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Caterina Sagnelli
@ast
Caterina Sagnelli
@en
Caterina Sagnelli
@es
Caterina Sagnelli
@nl
Caterina Sagnelli
@sl
type
label
Caterina Sagnelli
@ast
Caterina Sagnelli
@en
Caterina Sagnelli
@es
Caterina Sagnelli
@nl
Caterina Sagnelli
@sl
prefLabel
Caterina Sagnelli
@ast
Caterina Sagnelli
@en
Caterina Sagnelli
@es
Caterina Sagnelli
@nl
Caterina Sagnelli
@sl
P1053
K-9338-2016
P106
P1153
57193347759
6506192143
P21
P31
P3829
P496
0000-0002-6413-7810